IP Library Granted Patent US 7,258,973
Granted Patent B2
US 7,258,973 · App. 09/907,479 · Granted Aug 21, 2007

Method for detecting a differentially expressed sequence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,258,973
App. No.
09/907,479
Granted
Aug 21, 2007
Kind
B2
Abstract

This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.

Claims (12)

1. A method for determining the presence or absence of the sequence of SEQ ID NO: 7 in a cell, the method comprising:

a) contacting the cell with a probe or primer comprising a substantially purified oligonucleotide, said oligonucleotide consisting of a nucleic acid sequence complementary to the coding sequence of SEQ ID NO: 7, said probe or primer being from 8 consecutive nucleic acid residues in length up to and including the full length complementary sequence of SEQ ID NO: 7, said probe or primer being sufficient to hybridize under at least moderately stringent conditions with the coding sequence of SEQ ID NO: 7, and wherein said probe or primer comprises a label for detection; and

b) detecting hybridization of said probe or primer to a nucleic acid from said cell, and; optionally determining by sequence analysis whether the nucleic acid that hybridizes to said probe or primer is SEQ ID NO: 7.

2. A method for determining the presence or absence of the sequence of SEQ ID NO: 7 in a cell, the method comprising:

a) contacting the cell with a probe or primer comprising a substantially purified oligonucleotide, said oligonucleotide consisting of a nucleic acid sequence complementary to the coding sequence of SEQ ID NO: 7, said probe or primer being from 12 consecutive nucleic acid residues in length up to and including the full length complementary sequence of SEQ ID NO: 7, said probe or primer being sufficient to hybridize under at least moderately stringent conditions with the coding sequence of SEQ ID NO: 7, and wherein said probe or primer comprises a label for detection; and

b) detecting hybridization of said probe or primer to a nucleic acid from said cell, and; optionally determining by sequence analysis whether the nucleic acid that hybridizes to said probe or primer is SEQ ID NO: 7.

3. A method for determining the presence or absence of a nucleic acid sequence complementary to the sequence of SEQ ID NO: 7 in a cell, comprising:

a) contacting the cell with a probe or primer comprising a substantially purified oligonucleotide, said oligonucleotide consisting of the nucleic acid sequence of SEQ ID NO: 7, from 8 consecutive nucleic acid residues up to and including the full length of the coding sequence of SEQ ID NO: 7, said probe or primer being sufficient to hybridize under at least moderately stringent conditions with a nucleic acid complementary to the coding sequence of SEQ ID NO: 7, and wherein said probe or primer comprises a label for detection; and

b) detecting hybridization of said probe or primer to a nucleic acid from said cell, and; optionally determining by sequence analysis whether the nucleic acid that hybridizes to said probe or primer is complementary to SEQ ID NO: 7.

4. A method for determining the presence or absence of a nucleic acid sequence complementary to the sequence of SEQ ID NO: 7 in a cell, comprising:

a) contacting the cell with a probe or primer comprising a substantially purified oligonucleotide, said oligonucleotide consisting of the nucleic acid sequence of SEQ ID NO: 7, from 12 consecutive nucleic acid residues up to and including the full length of the coding sequence of SEQ ID NO: 7, said probe or primer being sufficient to hybridize under at least moderately stringent conditions with a nucleic acid complementary to the coding sequence of SEQ ID NO: 7, and wherein said probe or primer comprises a label for detection; and

b) detecting hybridization of said probe or primer to a nucleic acid from said cell, and; optionally determining by sequence analysis whether the nucleic acid that hybridizes to said probe or primer is complementary to the coding sequence of SEQ ID NO: 7.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2010
From: BAYER CORPORATION
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 024140/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2001
From: ASTLE, JON H.; BURGESS, CHRISTOPHER C.; CATINO, THEODORE J.; DWIVEDI, POORNIMA; LEWIS, MARCIA E.; MOLINO, GARY A.; MYEROW, SUSAN H.; THIAGALINGAM, ARUNTHATHI
To: BAYER CORPORATION
Reel/Frame 012240/0759 →